Fig. 1From: COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort studyDistribution of titers over elapsed time (days) after the first dose a and second dose b of the BNT162b2 Pfizer vaccine for lactating (n=14) and non-lactating (n=10) women. c Percentage of women with vaccine-induced antibodies (antibody titers ≥150) c)Back to article page